← Back to Search

Treatment for Autism Spectrum Disorder

N/A

Recruiting

Research Sponsored by Stalicla SA

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 0

Awards & highlights

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

Eligible Conditions

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 0

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 0

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 for reporting.

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Clinical characterisation of the ASD-Phen1 and ASD-Phen2 subpopulations.

Molecular characterization of the ASD-Phen1 and ASD-Phen2 subpopulations

Do I qualify?Apply below to find out

Stalicla SALead Sponsor

4 Previous Clinical Trials

268 Total Patients Enrolled

3 Trials studying Autism Spectrum Disorder

248 Patients Enrolled for Autism Spectrum Disorder

Joseph Palumbo, MDStudy DirectorStalicla SA

1 Previous Clinical Trials

15 Total Patients Enrolled

Baltazar Gomez-Mancilla, MD, PhDStudy DirectorStalicla SA

~173 spots leftby Dec 2024

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.